Work

Phase II trial of carboplatin (C) and bevacizumab (BEV) in patients (pts) with breast cancer brain metastases (BCBM).

Year: 2013

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2013.31.15_suppl.513

Authors: Nancy U. Lin, Rebecca Sue Gelman, W. Jerry Younger, Jessica Sohl, Rachel A. Freedman, A. Gregory Sorensen, Elizabeth Bullitt, Gordon J Harris, Daniel Morganstern, Bryan P. Schneider, Ian E. Krop, Eric P. Winer

Institutions: Dana-Farber Cancer Institute, Massachusetts General Hospital, Siemens Healthcare (United States), University of North Carolina at Chapel Hill, Indiana University Health, Indiana University Indianapolis, Indiana University Melvin and Bren Simon Comprehensive Cancer Center

Language: English

Topic: Brain Metastases and Treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2603244529

Cites:

Cited by: 42

Related to: 10